Skip to content

Intraoperative Haemodynamic Optimization Comparing Flow and Pressure Parameters

The Influence of Intraoperative Goal-directed Hemodynamic Therapy Based on Cardiac Index Trending on the Volume of Intraoperatively Administered Fluids and Vasoactive Agents in Comparison to Standard Pressure Monitoring in Patients Undergoing Major Elective Abdominal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02104687
Acronym
Flow-press
Enrollment
140
Registered
2014-04-04
Start date
2014-04-30
Completion date
2016-08-31
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenohemipancreatectomy, Extensive Bowel Surgery, Major Abdominal Surgery, Rectal Resection

Keywords

GTD, goal-directed haemodynamic therapy, CI, cardiac index, MAP, mean arterial pressure, CVP, central venous pressure

Brief summary

The purpose of the study is to confirm the hypothesis that flow treatment algorithm based on cardiac index trending by transesophageal Dopplerometry would result in reduced complications and reduced length of hospital stay in major abdominal surgery patients, when compared to patients treated with press treatment algorithm.

Detailed description

Despite standardisation of intraoperative care provided for risk surgery patients, the preoperative mortality remains higher than expected. The aim of the goal-directed heamodynamic therapy (GDT) is to improve the altered cardiovascular function and to reach the desired intraoperative values of oxygen supply (DO2) and cardiac index (CI). Standard haemodynamic measurements, such as heart rate (HR), mean arterial pressure (MAP) and central venous pressure (CVP) remain relatively unchanged despite reduced blood flow. However, GTD is able to detect early hypo perfusion abnormalities. The aim of goal-directed heamodynamic therapy, based on the titration of fluids and vasoactive drugs to physiological flow-related end points is to reduce perioperative complications, perioperative morbidity and mortality. We hypothesise, that following this treatment regimen results in reduced postoperative complications (primary endpoint) and reduced length of hospital stay (secondary endpoint).

Interventions

PROCEDUREFlow group

After induction, each patient will obtain Transesophageal Dopplerometry probe (CardioQ) in order to monitor the parameters of CI, FTc, PV and SVR.

PROCEDUREPress group

After induction, the parameters of MAP and CVP will be monitored in each of the patients.

Sponsors

University Hospital Ostrava
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 21 years of age and above * anticipated duration of surgery more than 120 minutes * estimated blood loss exceeding more than 15% of blood volume * American Society of Anesthesiology (ASA) classification 2 or 3 * indication for an arterial line and central venous catheter

Exclusion criteria

* pregnant or lactating women * age below 21 years of age * emergency surgery * American Society of Anesthesiology (ASA) classification 1 * sepsis and septic shock * severe cardiac arrhythmias * patients with pathology or intervention on oesophagus

Design outcomes

Primary

MeasureTime frameDescription
Pre-defined postoperative complications for up to 28 days after surgery24 monthsThe followed postoperative complications include infectious, respiratory, cardiovascular, abdominal, renal complications, massive postoperative bleeding and preoperative death.

Secondary

MeasureTime frameDescription
The length of hospitalization24 monthsLength of hospital stay will be obtained from the patient record.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026